Infinitopes
Oxford, GB · 6 known investors
Infinitopes develops immunotherapy treatments for cancer, focusing on immune-oncology and antigen discovery solutions aimed at improving patient outcomes and affordability in cancer care.
Founders & leadership
JK
Jonathan KwokCo-Founder, President & Chief Medical Officer
LN
Lian Ni LeeVP Preclinical & Co-Founder
Investors · 6
Companies House · registry record
View on Companies House ↗- Registered name
- INFINITOPES LIMITED
- Company number
- 13642685
- Status
- Active
- Company type
- Private limited company
- Incorporated
- 24 Sept 2021
- Registered office
- Bioescalator Innovation Building Oxford University, 696 Roosevelt Drive, Oxford, OX3 7FZ
- Nature of business (SIC)
- 72110 — Research and experimental development on biotechnology
- Accounts
- last made up to 31 Dec 2024 · next due 30 Sept 2026
- Confirmation statement
- last made up to 23 Sept 2025 · next due 7 Oct 2026
Current officers · 7
- Daniel Carey Cazel Hood — secretary, appointed 1 Jul 2025
- Joanna Elizabeth Brewer — director, appointed 1 Mar 2025
- Elliot Hershberg — director, appointed 19 Dec 2025
- Jonathan Kwok — director, appointed 24 Sept 2021
- Daniel Leonard Menichella — director, appointed 19 Mar 2025
- Hitesh Jayantilal Sanganee — director, appointed 5 Mar 2025
- Julia Schrameier — director, appointed 19 Dec 2025
Source: Companies House public register · retrieved 3 Aug 2026. Contains public sector information licensed under the Open Government Licence v3.0.